Murine CD7 shares antigenic cross-reactivity with HSP-60

Brandon A Howard1, Gregory D Sempowski, Richard M Scearce

  • 1Departments of Medicine, Duke University Medical Center, Duke Human Vaccine Institute, Durham, North Carolina, USA.

Hybridoma (2005)
|July 23, 2008
PubMed

Insights

Researchers developed rat monoclonal antibodies (MAbs) to mouse CD7 (mCD7). Unexpectedly, these MAbs targeted heat shock protein 60 (HSP-60), suggesting molecular mimicry and leaving the surface expression of mCD7 unresolved.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Human CD7 (hCD7) is an Ig superfamily molecule on T cells and NK cells, with known ligands and a role in endotoxic shock resistance.
  • Mouse CD7 (mCD7) protein distribution and specific monoclonal antibodies (MAbs) were previously unknown.

Purpose of the Study:

  • To develop rat MAbs against mCD7.
  • To investigate the distribution of mCD7 protein in mice.

Main Methods:

  • Immunization of rats with recombinant mCD7 protein to generate MAbs.
  • Western blot and immunoprecipitation of various mouse tissue extracts.
  • Epitope mapping of recognized sites on HSP-60 and recombinant mCD7.

Main Results:

  • Three rat MAbs were successfully raised against mCD7.
  • These MAbs cross-reacted with murine heat shock protein 60 (HSP-60) in both wild-type and CD7-deficient mice.
  • Epitope mapping revealed distinct, non-homologous epitopes on HSP-60 and mCD7.

Conclusions:

  • The generated anti-mCD7 MAbs exhibit molecular mimicry with HSP-60.
  • The surface expression of mCD7 in mice remains uncertain due to cross-reactivity with HSP-60.

Related Concept Videos